Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2017
Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study
Barbara M Norquist, Mark F Brady, Maria I Harrell, et al.
Gynecologic Oncology
|
February 22, 2025
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study
Paulina J Haight, Marilyn Sanchez, Samantha M Thomas, et al.
Gynecologic Oncology
|
May 25, 2023
Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study
Aaron M Praiss, Austin Miller, Judith Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2018
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu
Amanda N Fader, Dana M Roque, Eric Siegel, et al.
Gynecologic Oncology
|
March 8, 2025
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)
Allan Covens, Helen Q Huang, Bradley J Monk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2015
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study
Paul J Goodfellow, Caroline C Billingsley, Heather A Lankes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 27, 2025
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort study
Angeles Alvarez Secord, Victoria Bae-Jump, Floor Backes, et al.
Gynecologic Oncology
|
August 15, 2025
Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability
Bradley R Corr, Samantha M Thomas, Paulina J Haight, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2024
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors
Brian M Slomovitz, David Cibula, Weiguo Lv, et al.
The New England Journal of Medicine
|
March 27, 2023
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Ramez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2017
Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study
Barbara M Norquist, Mark F Brady, Maria I Harrell, et al.
Gynecologic Oncology
|
February 22, 2025
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study
Paulina J Haight, Marilyn Sanchez, Samantha M Thomas, et al.
Gynecologic Oncology
|
May 25, 2023
Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study
Aaron M Praiss, Austin Miller, Judith Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2018
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu
Amanda N Fader, Dana M Roque, Eric Siegel, et al.
Gynecologic Oncology
|
March 8, 2025
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)
Allan Covens, Helen Q Huang, Bradley J Monk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2015
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study
Paul J Goodfellow, Caroline C Billingsley, Heather A Lankes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 27, 2025
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort study
Angeles Alvarez Secord, Victoria Bae-Jump, Floor Backes, et al.
Gynecologic Oncology
|
August 15, 2025
Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability
Bradley R Corr, Samantha M Thomas, Paulina J Haight, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2024
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors
Brian M Slomovitz, David Cibula, Weiguo Lv, et al.
The New England Journal of Medicine
|
March 27, 2023
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Ramez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Page
of 6